ERG_VAX2

CAP-SELEX sample VAX2_ERG · 1 runs in PRJEB66722

Organism
Nucleic acid
DNA
Rounds available
R3
Sequences indexed
10,000

Top enriched sequences

More via API →
Sequence Length log2 FC P(active) Class Monotonicity
CACATTGACGCGCATTCACTATCCTACAACTACTTACACT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:288a35c8c447
40
TTACGGCATTATTGAATAGCCCCTACACCGTCAATATCGA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:c3d46ce23243
40
ACAACACCGCACCATGAACCCGTACCCCGTGCCTAAACCA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:929d5143120c
40
CGATTTAGTACGCATCACACGTTCCAACCTTCCACACTGT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:dd8f8336626d
40
CGTGACCGTAACTCATAGACTTCCGGTCAGCCTGACTGTG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:1372d155f9c2
40
ACACCGTATCGAGCGTGATGTCTCGCCATAATCGGTATAT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:132ec0645dd1
40
AGAGTACCTCGCTTCATGCTGCGATACGAAGCACCCCATG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:796c9a1d81c2
40
CACCTACCCAATCTGACCGAGACATTTACGTTAATTGATA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:ee530c8c87dc
40
TCCATTTATATCGAAGGCTAGTTGAACTTGCAAGATCAAG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:7bdcf5866fb5
40
CGCTCACCTACGCACAAAATAAGTAGCGCTAACCAACGTT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:1dada856a045
40
CATATACTCTGTGAATAGCTAACAGCACCTCACTTTCACG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:da92d84a5eb2
40
ATACTGACGTCTAATCGCAAAGAGGCCATGTGCGTTACAC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:db6178598d81
40
ACACTCCGTAAGTCATGTGTCGCGTGACTTCCGGACAGCG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:74cf4e2e0ff4
40
CGTGACCGGAAGTCTTGCGTAAACGTCCGGTCGAGCACCC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:ae4eae3679de
40
CCCTAGGGACCGTAAGCTCTTACGCGTCCGGTCCATGTCG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:ef7448b2148b
40
CCATTCCGGGCAGCGTTCTCAACGCTTGCGCCTACGTAAA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:4637d3e841d9
40
AGACACGCTATTCTTGATTATAACCACCCATTGCCACTTA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:15cc59928ba1
40
CTGCGTGGCGCACCCCGTAAGCGTGACTTCCGGTGCCGCT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:5e38b7d07ce0
40
CTTTGCTTCCGGCAAGTGCACAGGTACCGGAAGCACAATT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:48193659e6f0
40
CAAAGCGCAAATTTTATGCAGGACGATGCCAATAGCTTGG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:9ff082d2da8d
40
CTGCGACACCTCTTCGCGTGGTCCCCTCCAGGCATTAATC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:7237a74e69c2
40
CGCCATTCCCGTCCCTCGCTGGCAAAGACTCACTCCCACG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:bad693b06df6
40
CTGATATCTGTTGATACATAATGACAGGACGCTATGTGAC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:39fface14589
40
CGAACGTAAGCGAGTGAGGTATGAACACCGCTTCCGCCTC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:23d63a7406f3
40
TGCTTGCACTTCCGCCTGAAGATAAGGACGTAAGTTGTGC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:526ffeb27e91
40
CGCGCTTCCGCTACTAACCTAGTAACGTAAGCTATGCTAC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:a832a55e4b2a
40
CACGTATCACACTCATCACTCGTATTAACCTTGAGACCGC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:4398399c590f
40
TAGTTTAGCCGTTATGTGACATAGTAACATCCGGCAGTGC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:245a4e5c4d67
40
CGGAAGTGGGGCACCACTTACGCTAGCCATAAGGCCGCTA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:2bdb5a6a6640
40
GCGGAAGCTAGAGCAGTTTCCGGTTTGGCCACAACTTCCG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:47cb16dec5fb
40
CCCGTCATTAATCGATACACCCCAATCGATCGTATTAATT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:26162a9bc4de
40
ATTACGAACTCGCAATAGGCCATCCCCGCGAGCGTTTGTC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:5bf101048d90
40
CAGGCAGCATACAACCACCCGACCTAATGACCCTTATCCC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:d417a9a0c00d
40
GAAGTCAACACATAAAGACCGAATTGCCAAGGTGAATGAC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:9de78695359b
40
CGTAAGTGGACATCCGTTAGCATTGCAACCTTTAACACCT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:fd871a9aba65
40
TTTGCCGTCGCTGACACATTCATTAGCAATAAGCGCACGT
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:e5a9c331f21f
40
ACACAGTCTACATCCATCCACGTTTCACGTAAACAACACC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:233922966673
40
GCACCGGAAGACATGTTTTACGGTAACATCTCGACTGGTG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:1ed96c687b83
40
CACGCCGACGACCGGAAGTAGACTGACTTCCGGTCCTTCC
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:c3388f748605
40
TTCCAATTAGCACTATCAAGGACTAATAGCACAGCATTGA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:1e01c00f4eb5
40
GCAACATCCGGTCCCTCCCCGGAGACCGTATGTAGTGCGG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:c8f1d88340dd
40
GCGGTGAACGTAAATTGTGCATTGGTCCGTTCAGCGGGCG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:3dd107847e4d
40
TTCATGCCTAATCGATACTCGGTTACCGTTCATGGTATCA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:39dcdfa53b24
40
GGACGCGAATGCGATTGCATCCGGTCCACATCGCACCGCG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:71e55f73d0ba
40
ATGAAAGCCAGAAATGGTGGATAAGCATGAGTGGCTGAAG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:8cf05c316be2
40
TGCCCACATCCGGCGGTCATACCGTCCGTATGTGATAAGA
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:ad47cddc5e41
40
CCGGATACGCGAGCATCCGGTAGACATGCACACTCTACCG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:e9b4d5184010
40
CACGAAAGCACAACACAGACAACCCAATCCGCCTAAACTG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:d09ad9e57516
40
TGAAACGCGTAAGTCAGCACTTCCGGTTACGTCTTCAGGG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:0a86a64ed53f
40
CCCCTCCGTTAAGCTGTACTAACACACCTTCCGGCGTCGG
PANAPTA:P11308:ERG_VAX2:PRJEB66722:R3:cd13ae0e02c7
40

SELEX rounds

R3 ·final